According to its own statement, the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin, German Federal Financial Supervisory Authority) prohibited Uniox Gold LLC, which is based in Wyoming, USA, on November 3, 2026, from publicly offering certain investment products in the form of physical gold for purchase in Germany.
According to BaFin’s announcement, the measure concerns the following offerings:
-
The investment product “Gold Investment EUR 2,000” is affected.
-
The investment product “Gold Investment EUR 5,000” is also covered.
-
The prohibition also applies to the investment product “Gold Investment EUR 10,000”.
-
The investment product “Gold Investment EUR 20,000” is also included.
The regulatory measure is not yet final. However, it is immediately enforceable.
No Sales Prospectus for the Investment Products
BaFin Alleges Violation of the Vermögensanlagengesetz
According to BaFin, Uniox Gold LLC did not publish a sales prospectus approved by the financial supervisory authority for the public offering of the aforementioned investment products containing the information required under the Vermögensanlagengesetz (VermAnlG, German Investment Products Act). According to its announcement, BaFin considers this a violation of the Vermögensanlagengesetz; this assessment by the authority has not yet been established with final effect. On the basis of the immediately enforceable but not yet final prohibition, the company is currently not permitted to publicly offer the listed products for purchase in Germany.
Even before issuing the prohibition, BaFin had publicly stated that, contrary to § 6 Vermögensanlagengesetz (German Investment Products Act), no sales prospectus had been published for Uniox Gold LLC’s gold investments.
Requirements for Public Offerings
As a general rule, investment products may only be publicly offered in Germany if a sales prospectus approved by BaFin has previously been published. During the approval procedure, the financial supervisory authority examines whether the document contains the minimum information required by law. It also examines whether the presentation is comprehensible, coherent and therefore free of contradictions.
By contrast, approval does not include an examination of whether the information contained in the sales prospectus is substantively correct. Nor does BaFin investigate the issuer’s integrity or review the investment product being offered as part of this procedure.
Issuers must expressly draw attention to this limited scope of review in their sales prospectuses. The issuers are liable for the accuracy of the information provided in them. Whether an approved sales prospectus for a particular public offering has been filed with BaFin can be verified in the financial supervisory authority’s database of filed prospectuses.
Why Is the Absence of a Sales Prospectus So Legally Significant?
The legislature has established specific disclosure obligations for certain investment products. Under § 6 VermAnlG, a provider that publicly offers investment products in Germany must generally publish a sales prospectus in advance unless a statutory exemption applies.
This sales prospectus is intended to enable investors to obtain a comprehensive overview of the economic and legal framework of an investment.
This includes, in particular, information about:
-
the provider and the issuer,
-
the company’s financial position,
-
the specific structure of the investment product,
-
the use of investors’ funds,
-
the existing risks,
-
the repayment terms and
-
the financial safeguards for the investment.
The prospectus requirement is not merely a formality. It is intended to ensure that investors have access to the information prescribed by law before making an investment decision.
However, an important legal distinction must be made: by issuing its prohibition, BaFin does not automatically confirm that investment fraud has occurred. Nor does the prohibition mean that all investors’ funds have already been lost.
According to its announcement, BaFin assumes that the statutory requirements governing public offerings have been violated and has taken corresponding supervisory measures; the administrative order is not yet final.
Recovery of Invested Capital Under § 21 VermAnlG
§ 21 VermAnlG is of particular interest to affected investors. This provision expressly governs liability where a sales prospectus is absent.
Under certain conditions, an investor may require the issuer and the provider, as jointly and severally liable parties, to take back the acquired investment product and reimburse the purchase price, including the customary acquisition costs.
The Act therefore provides for a separate statutory right to unwind the transaction.
For investors in Uniox Gold LLC, this provision could constitute a material basis for recovering their investments, although any corresponding claims require the breach of the prospectus requirement to have been conclusively established; BaFin’s prohibition, which is not yet final, is merely an indication in this respect and does not, in itself, establish any existing claims. However, the statutory requirements must be assessed in each individual case. The following points are particularly relevant:
First: No Sales Prospectus
The product must in fact be an investment product subject to the prospectus requirement for which, contrary to § 6 VermAnlG, no sales prospectus was published.
Second: Date of Contract Formation
The acquisition transaction must have been concluded before the publication of a sales prospectus and within two years of the investment product’s first public offering in Germany.
Third: Domestic Acquisition from a Foreign Provider
As Uniox Gold LLC is based in the USA, § 21(3) VermAnlG is particularly relevant.
If the investment product was also publicly offered abroad, the claim generally only exists if the investment was acquired on the basis of a transaction concluded in Germany or an investment service performed at least in part in Germany.
Fourth: No Knowledge of the Prospectus Requirement
The claim is excluded if, at the time of acquisition, the investor knew that the provider was required to publish a sales prospectus.
If these requirements are met, the transaction may be eligible for rescission under § 21 VermAnlG.
Of particular importance is that the provision establishes joint and several liability on the part of the issuer and the provider. Investors should therefore obtain advice on which companies and individuals may legally be pursued as liable parties.
Further Claims for Damages Against Responsible Parties and Intermediaries
In addition to the specific recovery claim under § 21 VermAnlG, further civil-law claims may be available. In particular, the statements made to investors before and during the conclusion of the contract should be examined.
For example, if certain returns, collateral or gold holdings were promised but did not in fact exist or did not comply with the contractual agreements, this may give rise to further claims.
Potential Liability of Investment Intermediaries
Another important consideration concerns the individuals who brokered the gold investments or solicited investors on behalf of Uniox Gold LLC.
Such investment products are frequently distributed through independent intermediaries, distribution partners or individuals within investors’ personal circles. An individual legal assessment should also be carried out in this respect. Liability may arise, in particular, where intermediaries:
-
made inaccurate statements about the safety of the investment,
-
deliberately concealed risks,
-
presented unrealistic promises of returns as guaranteed,
-
misled investors regarding the actual use of their funds or
-
continued to solicit investors despite being aware of material problems.
Whether an intermediary is personally liable depends on their specific role, the representations they made and the statutory requirements for liability.
However, merely brokering an investment does not automatically give rise to personal liability.
Conclusion: Investors Should Have Their Legal Options Assessed Now
BaFin’s prohibition of Uniox Gold LLC’s public offering constitutes a significant supervisory action.
For investors, the failure to publish a sales prospectus required by law is particularly significant. § 21 VermAnlG provides a specific statutory cause of action that, under certain conditions, allows the investment transaction to be unwound.
Further claims under general civil law may also be available.
However, it should not be overlooked that enforcing such claims may present particular challenges because the company is based in the USA.
An early assessment of the contractual documents, payment flows and actual financial circumstances is therefore crucial.
Legal Assessment Under Capital Markets Law
The prospectus requirement and the scope of regulatory measures may be highly significant for companies, investors and private individuals. Particular account must be taken of the limited scope of the prospectus review and the fact that the prohibition is not yet final but is immediately enforceable. MTR Legal Rechtsanwälte advises clients on related matters as part of its capital markets law advisory services.
